Plasma Metabolites Forecast Occurrence and Prognosis for Patients With Diffuse Large B-Cell Lymphoma

BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin’s lymphoma with considerable heterogeneity and different clinical prognosis. However, plasma metabomics used to forecast occurrence and prognosis of DLBCL are rarely addressed. METHOD: A total of 65 volunteers including...

Descripción completa

Detalles Bibliográficos
Autores principales: Fei, Fei, Zheng, Meihong, Xu, Zhenzhen, Sun, Runbin, Chen, Xin, Cao, Bei, Li, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207198/
https://www.ncbi.nlm.nih.gov/pubmed/35734601
http://dx.doi.org/10.3389/fonc.2022.894891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207198/
https://www.ncbi.nlm.nih.gov/pubmed/35734601
http://dx.doi.org/10.3389/fonc.2022.894891

Ejemplares similares